161 related articles for article (PubMed ID: 35994889)
1. Pneumocystis jirovecii pneumonia [PJP]: An unrecognized concern in AML patients on Venetoclax.
Rainchwar S; Halder R; Singh R; Mehta P; Verma M; Agrawal N; Ahmed R; Bhurani D; Bansal N
Leuk Res; 2022 Oct; 121():106926. PubMed ID: 35994889
[TBL] [Abstract][Full Text] [Related]
2. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for
Awad M; Sierra CM; Mesghali E; Bahjri K
J Oncol Pharm Pract; 2021 Dec; 27(8):1936-1939. PubMed ID: 33307970
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia.
Paterno G; Guarnera L; Palmieri R; Del Prete V; Bonanni F; Buzzatti E; Moretti F; Casciani P; Savi A; Di Cave D; Maurillo L; Buccisano F; Venditti A; Del Principe MI
Mycoses; 2022 Feb; 65(2):233-238. PubMed ID: 34883533
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review.
Sierra CM; Daiya KC
Pharmacotherapy; 2022 Nov; 42(11):858-867. PubMed ID: 36222368
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis jirovecii pneumonia in patients with acute myeloid leukaemia.
Chang H; Kuo MC; Lin TL; Wu JH; Wang PN
Intern Med J; 2018 Jan; 48(1):81-83. PubMed ID: 29314523
[TBL] [Abstract][Full Text] [Related]
8. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
[TBL] [Abstract][Full Text] [Related]
9. The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.
Hardak E; Oren I; Dann EJ; Yigla M; Faibish T; Rowe JM; Avivi I
Acta Haematol; 2012; 127(2):110-4. PubMed ID: 22178955
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy.
Chua CC; Roberts AW; Reynolds J; Fong CY; Ting SB; Salmon JM; MacRaild S; Ivey A; Tiong IS; Fleming S; Brown FC; Loo S; Majewski IJ; Bohlander SK; Wei AH
J Clin Oncol; 2020 Oct; 38(30):3506-3517. PubMed ID: 32687450
[TBL] [Abstract][Full Text] [Related]
11. Indication for a Pneumocystis Prophylaxis Therapy in Patients with Vascular Anomalies Treated with PIK3/AKT/mTOR Pathway Inhibitors: Experts' Opinion and Systematic Review from the Literature.
Navarro M; Allemang-Trivalle A; Leducq S; Jonville-Bera AP; Maurier A; Zejli T; Edée AE; Harchaoui E; Giraudeau B; Maruani A
Dermatology; 2023; 239(6):942-951. PubMed ID: 37793356
[TBL] [Abstract][Full Text] [Related]
12. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation.
Zou J; Wang T; Qiu T; Zhou J; Chen Z; Ma X; Jin Z; Xu Y; Zhang L
Transpl Immunol; 2022 Jun; 72():101593. PubMed ID: 35367619
[TBL] [Abstract][Full Text] [Related]
13. UK paediatric oncology
Proudfoot RH; Phillips B
Arch Dis Child; 2021 Oct; 106(10):994-998. PubMed ID: 33632786
[TBL] [Abstract][Full Text] [Related]
14. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
15. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
[TBL] [Abstract][Full Text] [Related]
16. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
[TBL] [Abstract][Full Text] [Related]
17. Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis.
Haeusler GM; Slavin MA; Seymour JF; Lingaratnam S; Teh BW; Tam CS; Thursky KA; Worth LJ
Eur J Haematol; 2013 Aug; 91(2):157-63. PubMed ID: 23668894
[TBL] [Abstract][Full Text] [Related]
18. Two pediatric cases of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction of gastric lavage.
Takei H; Ishiwada N; Hishiki H; Takeshita K; Naito S; Endo M; Shimojo N
J Infect Chemother; 2019 Jun; 25(6):477-479. PubMed ID: 30797688
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis jirovecii Pneumonia with a Normal Early Chest Radiography and Complicated with Drug-Induced Immune Hemolytic Anemia: A Case Report.
Hamid NC; Malek KA; Nasir NM; Nasir NM
Am J Case Rep; 2022 Jul; 23():e936278. PubMed ID: 35879878
[TBL] [Abstract][Full Text] [Related]
20. Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers.
Paulsen G; Michaels MG; Danziger-Isakov L; Dipchand AI; Green M; McCulloch M
Pediatr Transplant; 2020 Feb; 24(1):e13609. PubMed ID: 31713958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]